1998
DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]
ŽÁKOVSKÁ, Alena; Olga NOVÁKOVÁ; Zdeňka BALCAROVÁ; Uli BIERBACH; Nicholas FARRELL et al.Základní údaje
Originální název
DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]
Autoři
Vydání
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 0014-2956
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Ukrajina
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.249
Označené pro přenos do RIV
Ano
Organizační jednotka
Přírodovědecká fakulta
Klíčová slova anglicky
DNA; platinum drug; quinoline; antitumor activity; conformation
Změněno: 5. 8. 2010 13:47, RNDr. Kamila Neplechová, Ph.D.
Anotace
V originále
Recent observations that several trans platinum complexes exhibit antitumor activity including activity in cisplatin-resistant tumor cells, violates the classical structure/activity relationships of platinum(II) complexes. According to these relationships, only bifunctional platinum(II) complexes with cis oriented leaving ligands should be therapeutically active. In order to contribute to the understanding of mechanisms underlying the antitumor activity of these new trans platinum analogs, various biochemical and biophysical methods as well as molecular modeling techniques were employed to study the modifications of DNA by antitumor trans[PtCl2(NH3)(quinoline)]. The results indicated that trans[PtCl2(NH3)(quinoline)] coordinated monofunctionally to DNA with a similar rate as transplatin. The overall rate of the rearrange ment to bifunctional adducts was also similar to that observed in the case of DNA modification by transplatin, i.e, it was relatively slow.
Návaznosti
| GA204/97/P028, projekt VaV |
|